IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 1.12 USD -4.27% Market Closed
Market Cap: 67m USD

Intrinsic Value

IGMS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IGMS stock under the Base Case scenario is 1.71 USD. Compared to the current market price of 1.12 USD, IGM Biosciences Inc is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IGMS Intrinsic Value
1.71 USD
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
IGM Biosciences Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
IGMS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for IGMS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

IGM Biosciences Inc
NASDAQ:IGMS
US
Biotechnology
Market Cap
66.8m USD
IPO
Sep 18, 2019
US
Biotechnology
Market Cap
66.8m USD
IPO
Sep 18, 2019
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about IGM Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
IGM Biosciences Inc

Current Assets 193.6m
Cash & Short-Term Investments 183.8m
Other Current Assets 9.8m
Non-Current Assets 72.1m
PP&E 71m
Other Non-Current Assets 1.1m
Efficiency

Free Cash Flow Analysis
IGM Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IGM Biosciences Inc

Revenue
2.7m USD
Operating Expenses
-196.9m USD
Operating Income
-194.2m USD
Other Expenses
-1.6m USD
Net Income
-195.8m USD
Fundamental Scores

IGMS Profitability Score
Profitability Due Diligence

IGM Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROIC is Increasing
Exceptional 1-Year Revenue Growth
Declining ROE
24/100
Profitability
Score

IGM Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

IGMS Solvency Score
Solvency Due Diligence

IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
54/100
Solvency
Score

IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IGMS Price Targets Summary
IGM Biosciences Inc

Wall Street analysts forecast IGMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IGMS is 1.91 USD with a low forecast of 0.76 USD and a high forecast of 3.15 USD.

Lowest
Price Target
0.76 USD
32% Downside
Average
Price Target
1.91 USD
71% Upside
Highest
Price Target
3.15 USD
181% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

IGM Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IGMS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IGMS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IGMS stock?

The intrinsic value of one IGMS stock under the Base Case scenario is 1.71 USD.

Is IGMS stock undervalued or overvalued?

Compared to the current market price of 1.12 USD, IGM Biosciences Inc is Undervalued by 35%.

Back to Top